Tower Research Capital LLC (Trc) Hcw Biologics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,787 shares of HCWB stock, worth $696. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,787
Previous 5,881
69.61%
Holding current value
$696
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding HCWB
# of Institutions
19Shares Held
3.13MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.02MShares$789,2280.01% of portfolio
-
Avantax Planning Partners, Inc.280KShares$109,0200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA182KShares$70,9630.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$70,5150.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$51,4760.0% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...